Last reviewed · How we verify
Risk of selected safety events — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Risk of selected safety events (Risk of selected safety events) — AstraZeneca.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Risk of selected safety events TARGET | Risk of selected safety events | AstraZeneca | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Risk of selected safety events CI watch — RSS
- Risk of selected safety events CI watch — Atom
- Risk of selected safety events CI watch — JSON
- Risk of selected safety events alone — RSS
Cite this brief
Drug Landscape (2026). Risk of selected safety events — Competitive Intelligence Brief. https://druglandscape.com/ci/risk-of-selected-safety-events. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab